Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris. - Queille-Roussel, C.; Nielsen, J.; Lacour, J.-P. (Journal of Dermatological Treatment, 2019)